The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses
Open accessAbstract
Phosphatidylinositol 3,4,5-trisphosphate (PtdInsP3) is rapidly produced upon exposure of neutrophils to the chemoattractant N-formylmethionyl-leucylphenylalanine (fMLP), and has been proposed to act as a second messenger mediating actin polymerization and respiratory-burst activity. Here we present evidence that wortmannin, a known inhibitor of respiratory-burst activity, acts on PtdIns 3-kinase, the enzyme producing PtdInsP3 from PtdIns(4,5)P2. Pretreatment of 32P-labelled human neutrophils with 100 nM wortmannin totally abolished fMLP-mediated PtdInsP3 production, raised PtdInsP2 levels, and did not affect cellular PtdInsP and PtdIns contents. The inhibitory effect on PtdInsP3 formation in intact cells was dose-dependent, with an IC50 of approximately 5 nM. Similar results were obtained with PtdIns 3-kinase immunoprecipitated by antibodies against the p85 regulatory subunit: wortmannin totally inhibited PtdIns3P production in immunoprecipitates at concentrations of 10-100 nM (IC50 approximately 1 nM). These results illustrate the direct and specific inhibition of PtdIns 3-kinase by wortmannin. Since agonist-mediated respiratory-burst activation is most sensitive to wortmannin (IC50 = 12 nM), this suggests that agonist-mediated PtdInsP3 formation is indispensable for this cell response. Neutrophils pretreated with wortmannin develop oscillatory changes in F-actin content, but actin polymerization in response to fMLP is not inhibited. This, and the absence of PtdInsP3 under these conditions, are in agreement with a modulatory role for PtdInsP3 in cytoskeletal rearrangements, but imply that PtdInsP3 production is not a primary event triggering elongation of actin filaments in neutrophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation.
Backer, J. M., Myers, M. G., Shoelson, S. E., Chin, D. J., Sun, X. J., Miralpeix, M., Hu, P., Margolis, B., Skolnik, E. Y., & Schlessinger, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05426.x · Cited by 1,008
Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P., & Cantley, L. C. (1989) · Cell · doi:10.1016/0092-8674(89)90182-7 · Cited by 908
Otsu, M., Hiles, I., Gout, I., Fry, M. J., Ruiz-Larrea, F., Panayotou, G., Thompson, A., Dhand, R., Hsuan, J., Totty, N., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90411-q · Cited by 765
Phosphatidylinositol 3-kinase: Structure and expression of the 110 kd catalytic subunit
Hiles, I. D., Otsu, M., Volinia, S., Fry, M. J., Gout, I., Dhand, R., Panayotou, G., Ruiz-Larrea, F., Thompson, A., Totty, N. F., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90166-a · Cited by 684
Fantl, W. J., Escobedo, J. A., Martin, G. A., Turck, C. W., del Rosario, M., McCormick, F., & Williams, L. T. (1992) · Cell · doi:10.1016/0092-8674(92)90444-h · Cited by 653
Kaplan, D. R., Whitman, M., Schaffhausen, B., Pallas, D. C., White, M., Cantley, L., & Roberts, T. M. (1987) · Cell · doi:10.1016/0092-8674(87)90168-1 · Cited by 646
Chemotaxis in Eukaryotic Cells: A Focus on Leukocytes and Dictyostelium
Devreotes, P. N., & Zigmond, S. H. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.003245 · Cited by 629
Purification and characterization of phosphoinositide 3-kinase from rat liver.
Carpenter, C. L., Duckworth, B. C., Auger, K. R., Cohen, B., Schaffhausen, B. S., & Cantley, L. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45429-9 · Cited by 627
Skolnik, E. Y., Margolis, B., Mohammadi, M., Lowenstein, E., Fischer, R., Drepps, A., Ullrich, A., & Schlessinger, J. (1991) · Cell · doi:10.1016/0092-8674(91)90410-z · Cited by 627
Cited by
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
Burgering, B. M. T., & Coffer, P. J. (1995) · Nature · doi:10.1038/376599a0 · Cited by 2,089
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery
Khalil, I. A., Kogure, K., Akita, H., & Harashima, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.8 · Cited by 1,240
Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in Inflammation
Hirsch, E., Katanaev, V. L., Garlanda, C., Azzolino, O., Pirola, L., Silengo, L., Sozzani, S., Mantovani, A., Altruda, F., & Wymann, M. P. (2000) · Science · doi:10.1126/science.287.5455.1049 · Cited by 1,209
Self-citationWalker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,197
Self-citationTen years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177
Chang, F., Lee, J. T., Navolanic, P. M., Steelman, L. S., Shelton, J. G., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402824 · Cited by 1,176
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040
PI3K signalling: the path to discovery and understanding
Vanhaesebroeck, B., Stephens, L., & Hawkins, P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3290 · Cited by 987
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Araki, N., Johnson, M. T., & Swanson, J. A. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.5.1249 · Cited by 949
“Wortmannin inhibits agonist-induced responses but not phorbol ester-induced responses in neutrophils (1, 2), indicating that PI 3-kinase functions upstream of protein kinase C in that signaling cascade.”
BackgroundPI3K in lymphocyte development, differentiation and activation
Okkenhaug, K., & Vanhaesebroeck, B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1056 · Cited by 810
Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 764
PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase
Chung, J., Grammar, T. C., Lemon, K. P., Kazlauskas, A., & Blenis, J. (1994) · Nature · doi:10.1038/370071a0 · Cited by 719
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M. J., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., & Panayotou, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1722 · Cited by 682
Self-citationStructure and function of phosphoinositide 3-kinases
Wymann, M. P., & Pirola, L. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00139-8 · Cited by 660
Self-citationBenard, V., Bohl, B. P., & Bokoch, G. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13198 · Cited by 645
Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., & Bussolino, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.882 · Cited by 626
The PX domains of p47phox and p40phox bind to lipid products of PI(3)K
Kanai, F., Liu, H., Field, S. J., Akbary, H., Matsuo, T., Brown, G. E., Cantley, L. C., & Yaffe, M. B. (2001) · Nature Cell Biology · doi:10.1038/35083070 · Cited by 611
Stephens, L., Smrcka, A., Cooke, F. T., Jackson, T. R., Sternweis, P. C., & Hawkins, P. T. (1994) · Cell · doi:10.1016/0092-8674(94)90237-2 · Cited by 594
Presynaptic facilitation by neuropeptide signaling mediates odor-driven food search
Root, C. M., Ko, K. I., Jafari, A., & Wang, J. W. (2011) · Cell · doi:10.1016/j.cell.2011.02.008 · Cited by 526
Divecha, N., & Irvine, R. F. (1995) · Cell · doi:10.1016/0092-8674(95)90409-3 · Cited by 567
The Gβγ Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101
Stephens, L. R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A. S., Thelen, M., Cadwallader, K., Tempst, P., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80187-7 · Cited by 557
Enhancing Macroautophagy Protects against Ischemia/Reperfusion Injury in Cardiac Myocytes
Hamacher-Brady, A., Brady, N. R., & Gottlieb, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603783200 · Cited by 555
Targeting phosphoinositide 3-kinase—Moving towards therapy
Marone, R., Cmiljanovic, V., Giese, B., & Wymann, M. P. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.10.003 · Cited by 548
Self-citationAn emerging focus on lipids in extracellular vesicles
Skotland, T., Sagini, K., Sandvig, K., & Llorente, A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.03.002 · Cited by 548
PDGF stimulates an increase in GTP–Rac via activation of phosphoinositide 3-kinase
Hawkins, P. T., Eguinoa, A., Qiu, R.-G., Stokoe, D., Cooke, F. T., Walters, R., Wennström, S., Claesson-Welsh, L., Evans, T., Symons, M., et al. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00080-7 · Cited by 542
Signalling through Class I PI3Ks in mammalian cells
Hawkins, P. T., Anderson, K. E., Davidson, K., & Stephens, L. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340647 · Cited by 540
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., Koon, H. B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C. L., & Kwiatkowski, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17222 · Cited by 538
Rapalogs and mTOR inhibitors as anti-aging therapeutics
Lamming, D. W., Ye, L., Sabatini, D. M., & Baur, J. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64099 · Cited by 531
Rapid vesicular translocation and insertion of TRP channels
Bezzerides, V. J., Ramsey, I. S., Kotecha, S., Greka, A., & Clapham, D. E. (2004) · Nature Cell Biology · doi:10.1038/ncb1150 · Cited by 528
Chemokines Trigger Immediate β2 Integrin Affinity and Mobility Changes
Constantin, G., Majeed, M., Giagulli, C., Piccio, L., Kim, J. Y., Butcher, E. C., & Laudanna, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00074-1 · Cited by 521
Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase
Ui, M., Okada, T., Hazeki, K., & Hazeki, O. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89056-8 · Cited by 520
The Akt/PKB pathway: molecular target for cancer drug discovery
Cheng, J. Q., Lindsley, C. W., Cheng, G. Z., Yang, H., & Nicosia, S. V. (2005) · Oncogene · doi:10.1038/sj.onc.1209088 · Cited by 498
Cross, D. A. E., Alessi, D. R., Vandenheede, J. R., McDowell, H. E., Hundal, H. S., & Cohen, P. (1994) · Biochemical Journal · doi:10.1042/bj3030021 · Cited by 478
Exploring the specificity of the PI3K family inhibitor LY294002
Gharbi, S. I., Zvelebil, M. J., Shuttleworth, S. J., Hancox, T., Saghir, N., Timms, J. F., & Waterfield, M. D. (2007) · Biochemical Journal · doi:10.1042/bj20061489 · Cited by 462
Bi, L., Okabe, I., Bernard, D. J., Wynshaw-Boris, A., & Nussbaum, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10963 · Cited by 452
Frech, M., Andjelkovic, M., Ingley, E., Reddy, K. K., Falck, J. R., & Hemmings, B. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8474 · Cited by 446
Rapamycin and mTOR kinase inhibitors
Ballou, L. M., & Lin, R. Z. (2008) · Journal of Chemical Biology · doi:10.1007/s12154-008-0003-5 · Cited by 442
Activation of the small GTP-binding proteins rho and rac by growth factor receptors
Nobes, C. D., Hawkins, P., Stephens, L., & Hall, A. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.1.225 · Cited by 438
Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling
Wennström, S., Hawkins, P., Cooke, F., Hara, K., Yonezawa, K., Kasuga, M., Jackson, T., Claesson-Welsh, L., & Stephens, L. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00087-7 · Cited by 435
ERK Activation Mediates Cell Cycle Arrest and Apoptosis after DNA Damage Independently of p53
Tang, D., Wu, D., Hirao, A., Lahti, J. M., Liu, L., Mazza, B., Kidd, V. J., Mak, T. W., & Ingram, A. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111598200 · Cited by 422
Phospholipid signalling in plants
Munnik, T., Irvine, R. F., & Musgrave, A. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00158-6 · Cited by 421
Collis, S. J., DeWeese, T. L., Jeggo, P. A., & Parker, A. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208332 · Cited by 412
Phosphoinositide 3-kinase signalling – which way to target?
Wymann, M. P., Zvelebil, M., & Laffargue, M. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00163-9 · Cited by 411
Self-citationA requirement for phosphatidylinositol 3-kinase in pseudopod extension
Cox, D., Tseng, C.-C., Bjekic, G., & Greenberg, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1240 · Cited by 410
Cook, D., Fry, M. J., Hughes, K., Sumathipala, R., Woodgett, J. R., & Dale, T. C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00830.x · Cited by 388
Matsui, T., Li, L., del Monte, F., Fukui, Y., Franke, T. F., Hajjar, R. J., & Rosenzweig, A. (1999) · Circulation · doi:10.1161/01.cir.100.23.2373 · Cited by 383
Neutrophil Priming: Pathophysiological Consequences and Underlying Mechanisms
Condliffe, A. M., Kitchen, E., & Chilvers, E. R. (1998) · Clinical Science · doi:10.1042/cs0940461 · Cited by 362
Clarke, J. F., Young, P. W., Yonezawa, K., Kasuga, M., & Holman, G. D. (1994) · Biochemical Journal · doi:10.1042/bj3000631 · Cited by 358
Kohn, A. D., Kovacina, K. S., & Roth, R. A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00103.x · Cited by 355
The activation of phosphatidylinositol 3-kinase by Ras
Kodaki, T., Woscholski, R., Hallberg, B., Rodriguez-Viciana Julian Downward, P., & Parker, P. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00177-9 · Cited by 329
Knall, C., Worthen, G. S., & Johnson, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3052 · Cited by 321
The Role of Quercetin, Flavonols and Flavones in Modulating Inflammatory Cell Function
Chirumbolo, S. (2010) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152810793358741 · Cited by 319
Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase
Bi, L., Okabe, I., Bernard, D. J., & Nussbaum, R. L. (2002) · Mammalian Genome · doi:10.1007/bf02684023 · Cited by 318
Suetsugu, S., Yamazaki, D., Kurisu, S., & Takenawa, T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00297-1 · Cited by 314
The molecular dissection of Fc gamma receptor mediated phagocytosis
Indik, Z., Park, J., Hunter, S., & Schreiber, A. (1995) · Blood · doi:10.1182/blood.v86.12.4389.bloodjournal86124389 · Cited by 312
Satin, B., Del Giudice, G., Della Bianca, V., Dusi, S., Laudanna, C., Tonello, F., Kelleher, D., Rappuoli, R., Montecucco, C., & Rossi, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1467 · Cited by 310
Jefferies, H. B. J., Cooke, F. T., Jat, P., Boucheron, C., Koizumi, T., Hayakawa, M., Kaizawa, H., Ohishi, T., Workman, P., Waterfield, M. D., et al. (2008) · EMBO reports · doi:10.1038/sj.embor.7401155 · Cited by 301
Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes
Yang, J., Bahreman, A., Daudey, G., Bussmann, J., Olsthoorn, R. C. L., & Kros, A. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00172 · Cited by 299
Condliffe, A. M. (2005) · Blood · doi:10.1182/blood-2005-03-0944 · Cited by 295
A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane
Mandelker, D., Gabelli, S. B., Schmidt-Kittler, O., Zhu, J., Cheong, I., Huang, C.-H., Kinzler, K. W., Vogelstein, B., & Amzel, L. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908444106 · Cited by 293
The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
Berndt, A., Miller, S., Williams, O., Le, D. D., Houseman, B. T., Pacold, J. I., Gorrec, F., Hon, W.-C., Ren, P., Liu, Y., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.293 · Cited by 292
Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiae
Strahl, T., & Thorner, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.01.015 · Cited by 291
Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function
Laffargue, M., Calvez, R., Finan, P., Trifilieff, A., Barbier, M., Altruda, F., Hirsch, E., & Wymann, M. P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00282-0 · Cited by 286
Self-citationThe Crystal Structure of the PX Domain from p40phox Bound to Phosphatidylinositol 3-Phosphate
Bravo, J., Karathanassis, D., Pacold, C. M., Pacold, M. E., Ellson, C. D., Anderson, K. E., Butler, P. J. G., Lavenir, I., Perisic, O., Hawkins, P. T., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00372-0 · Cited by 284
Ming, G.-L., Song, H.-J., Berninger, B., Inagaki, N., Tessier-Lavigne, M., & Poo, M.-M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80760-6 · Cited by 279
Shepherd, P. R., Navé, B. T., & Siddle, K. (1995) · Biochemical Journal · doi:10.1042/bj3050025 · Cited by 277
Phagocytosis and Intracellular Fate of Aspergillus fumigatus Conidia in Alveolar Macrophages
Ibrahim-Granet, O., Philippe, B., Boleti, H., Boisvieux-Ulrich, E., Grenet, D., Stern, M., & Latgé, J. P. (2003) · Infection and Immunity · doi:10.1128/iai.71.2.891-903.2003 · Cited by 277
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Rudelius, M., Pittaluga, S., Nishizuka, S., Pham, T. H.-T., Fend, F., Jaffe, E. S., Quintanilla-Martinez, L., & Raffeld, M. (2006) · Blood · doi:10.1182/blood-2006-04-015586 · Cited by 277
EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase.
Akimoto, K., Takahashi, R., Moriya, S., Nishioka, N., Takayanagi, J., Kimura, K., Fukui, Y., Osada, S.-I., Mizuno, K., Hirai, S.-I., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00414.x · Cited by 273
Collado, M., Medema, R. H., Garcı́a-Cao, I., Dubuisson, M. L. N., Barradas, M., Glassford, J., Rivas, C., Burgering, B. M. T., Serrano, M., & Lam, E. W.-F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000759200 · Cited by 271
Raynaud, F. I., Eccles, S. A., Patel, S., Alix, S., Box, G., Chuckowree, I., Folkes, A., Gowan, S., De Haven Brandon, A., Di Stefano, F., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1200 · Cited by 271
Arcaro, A., & Guerreiro, A. (2007) · Current Genomics · doi:10.2174/138920207782446160 · Cited by 269
Self-citationGelsolin is a downstream effector of rac for fibroblast motility
Azuma, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1362 · Cited by 265
Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R. J., & Sonenshein, G. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204257 · Cited by 265
Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells
WATSON, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.05.003 · Cited by 265
Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
Workman, P., Clarke, P. A., Raynaud, F. I., & van Montfort, R. L. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4355 · Cited by 264
Brown, W. J., DeWald, D. B., Emr, S. D., Plutner, H., & Balch, W. E. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.4.781 · Cited by 262
TOR2 is required for organization of the actin cytoskeleton in yeast
Schmidt, A., Kunz, J., & Hall, M. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13780 · Cited by 262
Takashima, A., Noguchi, K., Michel, G., Mercken, M., Hoshi, M., Ishiguro, K., & Imahori, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12257-5 · Cited by 260
Myou, S., Leff, A. R., Myo, S., Boetticher, E., Tong, J., Meliton, A. Y., Liu, J., Munoz, N. M., & Zhu, X. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030298 · Cited by 258
Dufourny, B., Alblas, J., van Teeffelen, H. A. A. M., van Schaik, F. M. A., van der Burg, B., Steenbergh, P. H., & Sussenbach, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31163 · Cited by 257
Matsuoka, K., Bassham, D. C., Raikhel, N. V., & Nakamura, K. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.6.1307 · Cited by 256
Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5.
Li, G., D'Souza-Schorey, C., Barbieri, M. A., Roberts, R. L., Klippel, A., Williams, L. T., & Stahl, P. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10207 · Cited by 255
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akinleye, A., Avvaru, P., Furqan, M., Song, Y., & Liu, D. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-88 · Cited by 254
Berger, P. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.13.1569 · Cited by 141
Uncoupling of Membrane Ruffling and Pinocytosis during Ras Signal Transduction
Li, G., D'Souza-Schorey, C., Barbieri, M. A., Cooper, J. A., & Stahl, P. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10337 · Cited by 85
Thiol Probes To Detect Electrophilic Natural Products Based on Their Mechanism of Action
Castro-Falcón, G., Hahn, D., Reimer, D., & Hughes, C. C. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00924 · Cited by 67
Kim, B.-C., Lee, M.-N., Kim, J.-Y., Lee, S.-S., Chang, J.-D., Kim, S.-S., Lee, S.-Y., & Kim, J.-H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24372 · Cited by 50
Lipponen, A., El-Osta, A., Kaspi, A., Ziemann, M., Khurana, I., KN, H., Navarro-Ferrandis, V., Puhakka, N., Paananen, J., & Pitkänen, A. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0519-z · Cited by 47
“Wortmannin, a radiosensitizer, is a phosphoinositide 3-kinase inhibitor [5] that also inhibits mTOR in vitro, a pathway involved in post-TBI recovery and epileptogenesis in several post-injury animal models [8, 92].”
Background
Metadata
- Authors
- Arcaro, A., & Wymann, M. P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1993-12-01
- Volume
- 296
- Issue
- 2
- Pages
- 297-301
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1818313483
- Cited by
- 1,140
- References
- 44
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.